Treatment with rhEREG (recombinant homo epiregulin) or autocrined EREG in conditioned medium (CM) both significantly increased PDL1 in different HNSCC cell lines (Fig. 1c, Supplementary Fig. 1s). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.